Ewa Maranda-Lech
14 Indiry Gandhi Str
Warsaw, MZ 02776, Poland
Warsaw, MZ 02776, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications
Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.
Journal: Leukemia & lymphoma
Published: August 10, 2026
Corrigendum to "Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study" EClinicalMedicine. 2025 Jul 25:86:103383.
Journal: EClinicalMedicine
Published: April 21, 2026
Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.
Journal: Haematologica
Published: March 20, 2026
Correction for: Accelerated chronic lymphocytic leukemia - characteristics and retrospective analysis of the Polish Adult Leukemia Study Group.
Journal: Contemporary oncology (Poznan, Poland)
Published: October 16, 2025
Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy - a multicenter study from Polish Adult Leukemia Group.
Journal: Annals of hematology
Published: September 20, 2025
Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial.
Journal: The Lancet. Haematology
Published: September 18, 2025
Anticoagulant therapy in patients with cancer and thrombocytopenia.
Journal: Journal of thrombosis and thrombolysis
Published: May 03, 2025
Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study.
Journal: EClinicalMedicine
Published: March 14, 2025
Last Updated: 09/26/2026